Big Cypress Acquisition
Why Robinhood?
You can watch BCYP and buy or sell other stocks, ETFs, and their options commission-free!About BCYP
SAB Biotherapeutics, Inc. is a clinical-stage, biopharmaceutical company, which engages in advancing a new class of immunotherapies leveraging fully-human polyclonal antibodies. The firm produces human polyclonal immunotherapies and its versatile DiversitAb platform is applicable for unmet needs in human diseases.
BCYP Key Statistics
Stock Snapshot
The current Big Cypress Acquisition(BCYP) stock price is $5.96, with a market capitalization of 283.75M. The stock trades at a price-to-earnings (P/E) ratio of -1.24.
On 2026-03-10, Big Cypress Acquisition(BCYP) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for Big Cypress Acquisition(BCYP) stock has reached 0, versus its average volume of 301.65K.
The stock's 52-week range extends from a low of $1.00 to a high of $6.60.
The stock's 52-week range extends from a low of $1.00 to a high of $6.60.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.